本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Mereo Biopharma Group Plc

1.69
-0.0450-2.60%
成交量:17.42万
成交额:29.49万
市值:2.68亿
市盈率:-5.33
高:1.73
开:1.73
低:1.68
收:1.73
52周最高:4.72
52周最低:1.47
股本:1.59亿
流通股本:1.00亿
量比:1.25
换手率:0.17%
股息:- -
股息率:- -
每股收益(TTM):-0.3162
每股收益(LYR):-0.2924
净资产收益率:-74.61%
总资产收益率:-35.13%
市净率:4.95
市盈率(LYR):-5.76

数据加载中...

2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/13

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/12/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/09/29

SEC问询函

CORRESP [Cover] - Correspondence
2021/09/07

SEC问询函

CORRESP [Cover] - Correspondence
2021/03/31

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/01

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/19

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/15

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/10/20

SEC问询函

CORRESP [Cover] - Correspondence
2020/09/29

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]